Fluorescence Angiography in the Assessment of DIEP Flap Perfusion
Indocyanine Green Fluorescence Angiography in the Assessment of Deep Inferior Epigastric Perforator (DIEP) Flap Perfusion
1 other identifier
interventional
60
1 country
1
Brief Summary
It is a single-center, prospective, randomized and controlled study focused in microsurgical autologous breast reconstruction. It involves applying indocyanine green (ICG) angiography for the study of the vascularization of DIEP flaps. The aim of the study is to determine whether there are differences in complications and aesthetic results when ICG is used to discard the poorly vascularized areas of the flap. The study includes adult women undergoing unilateral DIEP flap breast reconstruction. The calculated sample size is 60 patients. There are two groups. In group 1, the investigators use the usual clinical criteria to discard the poorly vascularized areas of the flap. In group 2, the investigators use the ICG to shape the flap.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Nov 2015
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 5, 2016
CompletedFirst Posted
Study publicly available on registry
May 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedApril 24, 2017
April 1, 2017
1.4 years
April 5, 2016
April 21, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Number of participants with fat necrosis as assessed by physical examination
Six months postoperatively
Number of participants with fat necrosis as assessed by ultrasonography
Six months postoperatively
Secondary Outcomes (10)
Number of participants with flap failure as assessed by physical examination
From intraoperative moment to one week postoperatively
Number of participants with wound infection as assessed by physical examination
From one day postoperatively to two weeks postoperatively
Number of participants with wound healing delay as assessed by physical examination
From two weeks postoperatively to two months postoperatively
Number of participants with reoperation
From immediate postoperative moment to one year postoperatively
Flap perfusion index as assessed by IC-CALC software (Pulsion Medical System)
Intraoperatively
- +5 more secondary outcomes
Study Arms (2)
Clinical assessment of flap perfusion
PLACEBO COMPARATORTailoring the flap according to clinical assessment of flap perfusion
Angiography assessment of flap perfusion
EXPERIMENTALTailoring the flap according to ICG Angiography assessment of flap perfusion
Interventions
After microvascular anastomosis is performed, the investigators clinically assess flap vascularization and the well vascularized tissue is marked by means of a dermographic pencil. Then the investigators administer 0,2mg/kg of ICG intravenously. The vascularization of the flap is also checked by means of the Photo Dynamic Eye (Pulsion Medical System) but finally the decision of discarding the poorly vascularized areas of the flap is made by clinical assessment.
After microvascular anastomosis is performed, the investigators administer 0,2mg/kg of ICG intravenously. Then the investigators check the vascularization of the flap by means of the Photo Dynamic Eye (Pulsion Medical System) and the poorly vascularized areas of the flap are discarded guided by ICG perfusion test.
Eligibility Criteria
You may qualify if:
- Mastectomized adult female patient
- Abdominal flap unilateral breast reconstruction indication
- Alloplastic breast reconstruction sequelae
- Enough amount of abdominal dermofat tissue to shape a breast with a primary closure of the donor site
You may not qualify if:
- DIEP flap bilateral breast reconstruction indication
- Previous abdominoplasty surgery
- Untreated psychiatric disease
- Untreated infection
- Indocyanine green or iodine hypersensitivity
- Hyperthyroidism, thyroid adenoma or thyroid autonomy
- Any concomitant disease or condition that, in the opinion of the investigator, can make the patient unsuitable to receive a microsurgical technique or to join the research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
La Paz University Hospital
Madrid, 28046, Spain
Related Publications (1)
Varela R, Casado-Sanchez C, Zarbakhsh S, Diez J, Hernandez-Godoy J, Landin L. Outcomes of DIEP Flap and Fluorescent Angiography: A Randomized Controlled Clinical Trial. Plast Reconstr Surg. 2020 Jan;145(1):1-10. doi: 10.1097/PRS.0000000000006393.
PMID: 31577664DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luis Landín Jarillo, MD, PhD
La Paz University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2016
First Posted
May 3, 2016
Study Start
November 1, 2015
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
April 24, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share